Does Rabbit Antithymocyte Globulin (Thymoglobuline®) Have a Role in Avoiding Delayed Graft Function in the Modern Era of Kidney Transplantation?

Table 4

Results of a retrospective analysis of prospectively collected from 45 frequency-matched DCD kidney transplant patients given rATG (2.5 mg/kg intraoperatively and 1.25 mg/kg on day 4) or daclizumab (2 x 1 mg/kg) as induction, with immediate CsA, MMF and steroids [74].

	rATG; (n=24)	Daclizumab; (n=21)	P value
DGF, %	52	65	0.08
Dialysis sessions, n	38	62	0.0001
Hospitalized days post-transplant, n	95,600	167,200	0.0004
BPAR, %	0	13	0.003
Mean healthcare cost per patient by year 1 (£)	14,904	18,929	0.002

BPAR, biopsy-proven acute rejection; CsA, cyclosporine; DCD, donation after cardiac death; MMF, mycophenolate mofetil; rATG, rabbit antithymocyte globulin; DGF, delayed graft function.